Mu opioid receptors acutely regulate adenosine signaling in striatal glutamate afferents

Abstract

Endogenous adenosine plays a crucial role in maintaining energy homeostasis and adenosine levels are tightly regulated across neural circuits. In the dorsal medial striatum (DMS) adenosine inhibits neurotransmitter release, but the source and mechanism underlying its accumulation are largely unknown. Opioids also inhibit neurotransmitter release in the DMS and influence adenosine accumulation after prolonged exposure. However, how these two neurotransmitter systems interact acutely is also largely unknown. This study demonstrates that activation of μ opioid receptors (MORs), but not δ opioid receptors (DORs) or κ opioid receptors (KORs), inhibits tonic activation of adenosine A₁Rs via a cyclic adenosine monophosphate (cAMP) dependent mechanism in both male and female mice. Further, selectively knocking-out MORs from thalamic presynaptic terminals and postsynaptic medium spiny neurons (MSNs) revealed that activation of MORs on D₁R positive MSNs, but not D₂R positive MSNs, is necessary to inhibit tonic adenosine signaling on presynaptic terminals. Given the role of D₁R positive MSNs in movement and motivated behaviors, these findings reveal a novel mechanism by which these neurons regulate their own synaptic inputs.

Significance Statement:

Understanding interactions between neuromodulatory systems within brain circuits is a fundamental question in neuroscience. The present work uncovers a novel role of opioids in acutely inhibiting adenosine accumulation and subsequent adenosine receptor signaling in the striatum by inhibiting the production of cAMP. Adenosine receptor signaling regulates striatal neurotransmitters including glutamate, GABA, dopamine and acetylcholine. Furthermore, interactions between adenosine_2A receptors and numerous other GPCRs, including D₂ dopamine and CB₁ cannabinoid receptors, suggest that endogenous adenosine broadly modulates striatal GPCR signaling. Additionally, this work discovered that the source of resting endogenous extracellular adenosine is likely D₁, but not D₂ receptor positive MSNs, suggesting that opioid signaling and manipulation of D₁R-expressing MSN cAMP activity can broadly affect striatal function and behavior.